Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials

Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of substantial vision can occur. Understanding the processes that lead to loss of vision may lead to preventive strategies. To determine the incid...

Full description

Bibliographic Details

Published in:	JAMA ophthalmology Vol. 132; no. 8; p. 915
Main Authors:	Ying, Gui-shuang, Kim, Benjamin J, Maguire, Maureen G, Huang, Jiayan, Daniel, Ebenezer, Jaffe, Glenn J, Grunwald, Juan E, Blinder, Kevin J, Flaxel, Christina J, Rahhal, Firas, Regillo, Carl, Martin, Daniel F
Format:	Journal Article
Language:	English
Published:	United States 01.08.2014
Subjects:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Humans Incidence Macular Degeneration - drug therapy Macular Degeneration - physiopathology Middle Aged Ranibizumab Visual Acuity
ISSN:	2168-6173, 2168-6173
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!